CD14 and chronic myelogenous leukemia, BCR-ABL1 positive: Herein, we present that I13 could overcome the differentiation block in CML cells harboring T315I-mutated BCR-ABL and wild-type BCR-ABL, characterized by the changed morphology and increased expression of CD11b, CD13, CD14, or CD15.